CADRENAL THERAPEUTICS INC (CVKD:NASDAQ)
$5.19 0 (0%)
Analysed CADRENAL THERAPEUTICS INC (CVKD:NASDAQ) News Sources
Cadrenal Therapeutics Highlights Research Supporting 12-LOX Inhibition in Reducing Inflammation in Obesity and Type 2 Diabetes
12-03-2026
yahoo.com
Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
13-03-2026
yahoo.com
OTC Markets Hosts Virtual Investor Presentation with Quang Pham, Chairman and CEO of Cadrenal Therapeutics, and David Bautz, PhD, Senior Analyst at Zacks SCR
20-03-2026
yahoo.com
Cadrenal Therapeutics Reports Fourth Quarter 2025 Financial Results; Provides Corporate Update on CAD-1005 Program for HIT Following End-of-Phase 2 FDA Meeting
31-03-2026
yahoo.com
CVKD: Results Show 12-LOX Inhibition Targets Inflammation from Obesity and Type 2 Diabetes
08-04-2026
yahoo.com
Analysts Adjust Cadrenal Therapeutics, Inc. (CVKD) Valuation After Including CAD-1005 Program
21-04-2026
yahoo.com
Cadrenal Therapeutics Announces End-of-Phase 2 Meeting with the FDA and Pivotal Phase 3 Registration Path for CAD-1005 in Heparin-Induced Thrombocytopenia (HIT)
30-04-2026
yahoo.com
Cadrenal Therapeutics Reports First Quarter 2026 Financial Results and Provides Phase 3 Development Update on CAD-1005 Following End-of-Phase 2 Meeting with FDA
07-05-2026
yahoo.com
CVKD: Designing Phase 3 Trial for CAD-1005 in HIT
08-05-2026
yahoo.com
Cadrenal Therapeutics to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026
19-05-2026
yahoo.com
What is the current price of CADRENAL THERAPEUTICS INC (CVKD:NASDAQ)?
The current price of CADRENAL THERAPEUTICS INC (CVKD:NASDAQ) is $5.19.
CADRENAL THERAPEUTICS INC (CVKD:NASDAQ) absolute price change since previous trading day?
The absolute price change of CADRENAL THERAPEUTICS INC (CVKD:NASDAQ) since the previous trading day is $0.
CADRENAL THERAPEUTICS INC (CVKD:NASDAQ) percentage price change since previous trading day?
The percentage price change of CADRENAL THERAPEUTICS INC (CVKD:NASDAQ) since the previous trading day is 0%.
What is the most recent average sentiment score for CADRENAL THERAPEUTICS INC (CVKD:NASDAQ)?
The most recent average sentiment score for CADRENAL THERAPEUTICS INC (CVKD:NASDAQ) is 77 out of 100.
What is the most recent average sentiment for CADRENAL THERAPEUTICS INC (CVKD:NASDAQ)?
The most recent sentiment for CADRENAL THERAPEUTICS INC (CVKD:NASDAQ) is .
SEC-8K** Filing Available For CADRENAL THERAPEUTICS INC (CVKD:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.